Search Results for "sco"
Montai Therapeutics Leverages NVIDIA NIM for Multimodal AI Drug Discovery
Montai Therapeutics collaborates with NVIDIA to develop a multimodal AI platform for drug discovery using NVIDIA NIM microservices.
ElevenLabs Unveils Realistic Scottish Accent Text-to-Speech Technology
ElevenLabs introduces advanced Scottish accent text-to-speech technology, offering nine authentic regional accents. Ideal for storytelling, marketing, and more.
Binance Pool Introduces Merged Mining for LTC with Rewards in LTC, DOGE, and BEL
Binance Pool launches Bellscoin (BEL) merged mining, allowing users to mine Litecoin (LTC) and earn rewards in LTC, Dogecoin (DOGE), and BEL.
Binance Pool Introduces Merged Mining for LTC, DOGE, and Bellscoin (BEL)
Binance Pool now supports merged mining for Litecoin (LTC), offering rewards in LTC, Dogecoin (DOGE), and Bellscoin (BEL).
Yale, Moderna, and NVIDIA Harness Quantum Computing for Drug Discovery
Yale, Moderna, and NVIDIA explore quantum machine learning to enhance drug discovery. The collaboration focuses on GPU-accelerated simulation of quantum algorithms for predicting molecular properties.
AI Foundation Models Propel Scientific Discovery Forward
Microsoft's AI foundation models, such as MatterGen and Aurora, are enhancing scientific research by accelerating materials discovery and improving weather predictions.
NVIDIA's GPU Innovations Revolutionize Drug Discovery Simulations
NVIDIA's latest GPU optimization techniques, including CUDA Graphs and C++ coroutines, promise to accelerate pharmaceutical research by enhancing molecular dynamics simulations.
AI-Driven Drug Discovery Revolutionizes Treatment Development
AI's integration into drug discovery is transforming the development of treatments, reducing time and cost significantly, according to NVIDIA's blog.
Binance Pay Offers 11% Discount on Mobile Top-ups with No Minimum Spend
Binance Pay users can avail an 11% discount on mobile top-ups with no minimum spend, applicable in selected regions on a first-come, first-served basis, capped at 2 USDT per user.
NVIDIA Launches cuEquivariance to Revolutionize AI in Drug and Material Discovery
NVIDIA introduces cuEquivariance, a new math library aimed at enhancing AI models for scientific discovery, addressing challenges in symmetry transformations and computational efficiency.
Mitsui & Co's Xeureka Utilizes NVIDIA AI for Secure Drug Discovery
Xeureka, a subsidiary of Mitsui & Co, leverages NVIDIA's AI platform to safely share healthcare data, enhancing drug discovery efforts through advanced confidential computing.
NVIDIA Introduces BioNeMo Blueprint to Revolutionize Protein Binder Design
NVIDIA unveils the BioNeMo Blueprint, a new AI-powered approach to accelerate protein binder design in drug discovery, leveraging GPU-accelerated microservices.